MENU
+Compare
PEN
Stock ticker: NYSE
AS OF
Dec 18, 04:59 PM (EDT)
Price
$238.72
Change
-$8.83 (-3.57%)
Capitalization
8.64B

PEN Penumbra Forecast, Technical & Fundamental Analysis

a manufacturer of medical devices

PEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for PEN with price predictions
Dec 17, 2024

PEN sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for PEN moved above the 200-day moving average on November 18, 2024. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 56 cases where PEN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on December 11, 2024. You may want to consider a long position or call options on PEN as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PEN advanced for three days, in of 333 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 263 cases where PEN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for PEN moved out of overbought territory on December 05, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for PEN turned negative on November 27, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PEN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PEN broke above its upper Bollinger Band on December 11, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PEN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.138) is normal, around the industry mean (23.300). P/E Ratio (93.703) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (8.052) is also within normal values, averaging (43.338).

View a ticker or compare two or three
PEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

PEN is expected to report earnings to rise 5.21% to 89 cents per share on February 25

Penumbra PEN Stock Earnings Reports
Q4'24
Est.
$0.89
Q3'24
Beat
by $0.16
Q2'24
Beat
by $0.08
Q1'24
Beat
by $0.03
Q4'23
Beat
by $0.68
The last earnings report on October 30 showed earnings per share of 85 cents, beating the estimate of 68 cents. With 414.16K shares outstanding, the current market capitalization sits at 8.64B.
A.I. Advisor
published General Information

General Information

a manufacturer of medical devices

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
One Penumbra Place
Phone
+1 510 748-3200
Employees
4200
Web
https://www.penumbrainc.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GDOC33.12N/A
N/A
Goldman Sachs Future Health Care Eq ETF
PJUL41.55-0.01
-0.02%
Innovator U.S. Equity Power BffrETF™-Jul
IGIB52.19-0.01
-0.03%
iShares 5-10 Year invmt Grd Corp Bd ETF
COM28.55-0.09
-0.31%
Direxion Auspice Broad Cmdty Strat ETF
FLEE28.80-0.10
-0.34%
Franklin FTSE Europe ETF

PEN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PEN has been loosely correlated with BIO. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if PEN jumps, then BIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PEN
1D Price
Change %
PEN100%
+0.13%
BIO - PEN
36%
Loosely correlated
-1.49%
MMSI - PEN
34%
Loosely correlated
-3.24%
QDEL - PEN
34%
Loosely correlated
-1.85%
NVST - PEN
33%
Loosely correlated
-1.69%
PODD - PEN
32%
Poorly correlated
-0.81%
More